Skip to content

#Pax6

14 public questions tagged with this topic.

What happens when Pax6 is overexpressed in surface ectoderm?

Pax6 functions as sufficient master regulator for lens program. Misexpression experiments using PAX6 cDNA electroporated into embryonic chick surface ectoderm outside normal eye region, or promoter driven in frog epidermis, activates endogenous Sox2, FoxE3, Maf genes and delta-crystallin, culminating in formation of ectopic lens placodes and lens vesicles with fiber differentiation. This demonstrates that providing Pax6 competence factor can bypass requirement for optic vesicle signal in regions that already possess low levels of BMP and FGF. Thus overexpression converts non-lens ectoderm toward lens fate, confirming key competence role.

Ref: Altmann et al. 1997; Gilbert, Developmental Biology Chapter: Pax6 overexpression induces ectopic lens formation.

Which condition is caused by mutations in Pax6?

Human PAX6 heterozygous loss-of-function mutations cause aniridia, autosomal dominant condition characterized by near complete absence of iris tissue, foveal hypoplasia, cataract and corneal pannus. During development, reduced Pax6 dosage impairs maintenance of optic cup rim that generates iris stroma and pigmented epithelium, as well as surface ectoderm differentiation into corneal epithelium. Patient limbal stem cells fail to maintain transparency. Mouse small-eye heterozygotes parallel phenotype. Aniridia demonstrates critical role for precise Pax6 levels in anterior segment development beyond early lens induction, making it classic example of haploinsufficiency in eye disease.

Ref: Ton et al. Cell 1991; Gilbert Developmental Biology 12th ed., Chapter 19: PAX6 mutations cause aniridia.

What happens in Pax6 heterozygous mutants?

Pax6 exhibits haploinsufficiency. Heterozygous Small eye mice carry one null allele, reducing transcription factor dosage to 50 percent. Eye field still forms but retinal progenitor pool proliferation, lens induction and iris development are attenuated. Resulting eyes are significantly smaller, termed microphthalmia, with cataracts, corneal opacification and underdeveloped retina. Dosage threshold differs among targets; lens placode markers require higher Pax6 levels than optic vesicle evagination. Human PAX6 heterozygotes show aniridia, similar dosage effect. Complete absence requires homozygous null, whereas heterozygous produces small eye phenotype reflecting quantitative gene regulation.

Ref: Glaser et al. Science 1990; Gilbert Chapter 7: Pax6 dosage - heterozygous small eye formation.

Which experiment demonstrated that Pax6 is required in surface ectoderm for lens formation?

Competence requirement was proven by tissue recombination. Fujiwara et al. used rSey rats carrying Pax6 mutation. Wild-type optic vesicle grafted onto wild-type head ectoderm induces lens efficiently. When same wild-type vesicle is apposed to Pax6 mutant ectoderm, no lens forms despite normal inductive signals. Reverse combination, mutant optic vesicle with wild-type ectoderm, still induces lens, showing Pax6 needed in responding tissue not inducer. This demonstrates transcription factor acts cell-autonomously in ectoderm to confer ability to interpret BMP and FGF cues, rather than affecting signaling source or neural crest components.

Ref: Fujiwara et al. 1994; NCBI Bookshelf, Developmental Biology Chapter: Induction and Competence experiment - Pax6 in surface ectoderm.

What happens in Pax6 mutant mice?

Pax6 homozygous null mice known as Small eye mutants display complete absence of eyes, nose and pancreas defects. Genetic lesion eliminates functional paired and homeodomain, preventing expression of downstream lens, retinal and corneal genes. Optic vesicle forms initially but arrests because retinal progenitor specification fails and surface ectoderm remains incompetent. Contact between vesicle and ectoderm cannot initiate crystallin expression. Heterozygotes show microphthalmia with small lens and iris defects, reflecting dosage sensitivity. Thus loss of both alleles results in anophthalmia rather than isolated lens abnormality, demonstrating master control function across whole eye field.

Ref: Hill et al., Nature 1991; Gilbert, Developmental Biology, Chapter 7: Pax6 mutant mouse phenotype - eyeless.

Which of the following best describes the role of Pax6 in lens development?

Competence describes tissue ability to respond to an inducer. In presumptive lens ectoderm, Pax6 is expressed well before optic vesicle contact as part of preplacodal region specification by Six1, Eya1. It remodels chromatin and directly binds to enhancers of FoxE3, Sox2 and crystallins, keeping them poised. Upon arrival of BMP4 and FGF signals from optic vesicle, Pax6-positive ectoderm rapidly transcribes lens genes. Pax6 does not itself provide inductive signal nor inhibit BMP, but creates responsive state. Conditional removal from surface ectoderm blocks lens despite intact signaling center.

Ref: Gilbert, Developmental Biology, 11th ed., Chapter 12: Role of Pax6 in conferring lens-forming competence to ectoderm.

Which signaling molecule is required for lens differentiation and activates Sox2?

BMP4 expressed in optic vesicle and periocular mesenchyme plays biphasic roles in lens specification. Early BMP4 activates Smad-dependent transcription of Sox2 in head ectoderm that already expresses Pax6, allowing formation of Pax6-Sox2 complex on delta-crystallin enhancer. This triggers lens placode thickening and invagination. Later BMP activity must be attenuated by Noggin in neural retina to permit differentiation. Conditional deletion of Bmpr1a in mouse surface ectoderm abolishes Sox2 upregulation and lens vesicle formation, while exogenous BMP beads rescue competence, confirming requirement for differentiation signaling.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 7: BMP signaling in lens induction and Sox2 activation.

What happens in a Pax6 knockout mouse?

Pax6 knockout mouse homozygous null exhibits complete failure of eye morphogenesis including absence of lens, cornea, and retina. Optic vesicle forms initially but remains small rudiment failing to contact surface ectoderm and regresses because reciprocal maintenance cues absent. Lens placode never thickens due to lack of ectodermal competence factor, cornea does not differentiate transparently, but primary defect is total eyeless phenotype not limited to cornea or lens alone. Presumptive retina fails to expand into cup, demonstrating Pax6 requirement upstream of entire eye program governing both optic cup and lens lineages and survival.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 12: Pax6 knockout – complete anophthalmia and lens failure.

What happens when Pax6 is overexpressed in surface ectoderm?

Overexpression of Pax6 in competent head surface ectoderm results in ectopic lens formation at sites outside normal eye region. Transgenic misexpression or electroporation of Pax6 into head ectoderm induces ectopic Sox2, Six3, L-Maf, and crystallin expression forming additional lens vesicles that may recruit surrounding mesenchyme and attempt optic cup-like differentiation. No suppression of FGF signaling or inhibition of Sox2 occurs; instead synergistic activation. Surface ectoderm normally expresses low Pax6, elevating levels confers increased competence recapitulating master regulatory property previously described for eyeless gene in Drosophila eye induction and vertebrates.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 12: Pax6 overexpression inducing ectopic lens formation.

Which condition is caused by mutations in Pax6?

Mutations in PAX6 transcription factor cause aniridia, congenital absence or severe hypoplasia of iris, accompanied by corneal opacification, cataracts, foveal hypoplasia, and nystagmus. Pax6 continues expression in iris, cornea, retina throughout development maintaining ocular progenitor gene networks. Dominant haploinsufficiency reduces DNA binding to target promoters. Cataract alone typically results from crystallin mutations, retinal detachment from other causes, myopia polygenic. Aniridia represents classic dosage-sensitive phenotype of PAX6 linked to 11p13 deletion, demonstrating pleiotropic eye regulatory role beyond lens induction and corneal maintenance.

Ref: NCBI Bookshelf, Molecular Biology of Eye: PAX6 mutations causing aniridia and ocular anomalies.

What happens in Pax6 heterozygous mutants?

Pax6 exhibits dosage-sensitive haploinsufficient phenotype. Heterozygous mutants (Pax6 +/-) display small eye phenotype known as Small eye in mouse or Sey, microphthalmia, lens hypoplasia, and corneal opacities due to reduced Pax6 dosage insufficient to fully activate lens and retinal targets. Homozygous loss eliminates eye entirely. No extra lens forms, neural retina specification requires Pax6 but small eye includes both lens and retina hypoplasia rather than loss of neural retina alone, reflecting proportionally decreased activation of Six3, Sox2, and crystallin promoters by half dosage of transcription factor.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 12: Pax6 haploinsufficiency – small eye phenotype in heterozygotes.

Which experiment demonstrated that Pax6 is required in surface ectoderm for lens formation?

Requirement of Pax6 in surface ectoderm for lens formation was demonstrated by tissue recombination: grafting wild-type optic vesicle onto Pax6-deficient head ectoderm from Small eye mutant fails to induce lens placode or crystallin expression, whereas Pax6-deficient optic vesicle grafted onto wild-type ectoderm still induces lens. Knockout of Pax6 in optic vesicle alone does not block lens, overexpression in cup does not address ectodermal necessity, neural crest knockout irrelevant. Mosaic recombinant experiment proves cell-autonomous competence role of Pax6 within responding surface ectoderm, not inducing tissue itself.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 12: Pax6 tissue recombination – requirement in surface ectoderm.